Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 932

    1.

    T-cell tolerance by dendritic cells and macrophages as a mechanism for the major histocompatibility complex-linked resistance to autoimmune diabetes.

    Thiessen S, Serra P, Amrani A, Verdaguer J, Santamaria P.

    Diabetes. 2002 Feb;51(2):325-38.PMID: 11812739 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Autoantigen-independent deletion of diabetogenic CD4+ thymocytes by protective MHC class II molecules.

    Schmidt D, Amrani A, Verdaguer J, Bou S, Santamaria P.

    J Immunol. 1999 Apr 15;162(8):4627-36.PMID: 10202002 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    A mechanism for the major histocompatibility complex-linked resistance to autoimmunity.

    Schmidt D, Verdaguer J, Averill N, Santamaria P.

    J Exp Med. 1997 Oct 6;186(7):1059-75.PMID: 9314555 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Major histocompatibility complex class II molecules can protect from diabetes by positively selecting T cells with additional specificities.

    Lühder F, Katz J, Benoist C, Mathis D.

    J Exp Med. 1998 Feb 2;187(3):379-87.PMID: 9449718 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    MHC class II molecules play a role in the selection of autoreactive class I-restricted CD8 T cells that are essential contributors to type 1 diabetes development in nonobese diabetic mice.

    Serreze DV, Holl TM, Marron MP, Graser RT, Johnson EA, Choisy-Rossi C, Slattery RM, Lieberman SM, DiLorenzo TP.

    J Immunol. 2004 Jan 15;172(2):871-9.PMID: 14707058 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Relative resistance to nasally induced tolerance in non-obese diabetic mice but not other I-A(g7)-expressing mouse strains.

    Quinn A, Melo M, Ethell D, Sercarz EE.

    Int Immunol. 2001 Oct;13(10):1321-33.PMID: 11581177 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.

    Noorchashm H, Lieu YK, Noorchashm N, Rostami SY, Greeley SA, Schlachterman A, Song HK, Noto LE, Jevnikar AM, Barker CF, Naji A.

    J Immunol. 1999 Jul 15;163(2):743-50.PMID: 10395666 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    On the self-referential nature of naive MHC class II-restricted T cells.

    Viret C, He X, Janeway CA Jr.

    J Immunol. 2000 Dec 1;165(11):6183-92.PMID: 11086052 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Analysis of the role of variation of major histocompatibility complex class II expression on nonobese diabetic (NOD) peripheral T cell response.

    Ridgway WM, Ito H, Fassò M, Yu C, Fathman CG.

    J Exp Med. 1998 Dec 21;188(12):2267-75.PMID: 9858513 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Cellular expression requirements for inhibition of type 1 diabetes by a dominantly protective major histocompatibility complex haplotype.

    Chen YG, Silveira PA, Osborne MA, Chapman HD, Serreze DV.

    Diabetes. 2007 Feb;56(2):424-30.PMID: 17259387 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Thymic and postthymic regulation of diabetogenic CD8 T cell development in TCR transgenic nonobese diabetic (NOD) mice.

    Kanagawa O, Shimizu J, Vaupel BA.

    J Immunol. 2000 May 15;164(10):5466-73.PMID: 10799914 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.
    19.

    Autoimmune tolerance and type 1 (insulin-dependent) diabetes mellitus.

    Nossal GJ, Herold KC, Goodnow CC.

    Diabetologia. 1992 Dec;35 Suppl 2:S49-59. Review.PMID: 1478378 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data